Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency

NCT05461690 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang Cancer Hospital

Collaborators